P2Y12 Inhibitor‐Based Single Antiplatelet Therapy Versus Conventional Dual Antiplatelet Therapy After Newer‐Generation Drug‐Eluting Stent Implantation in Chronic and Acute Coronary Syndromes: A Systematic Review and Meta‐Analysis of Randomized Clinical Trials

Background P2Y12 inhibitor‐based single antiplatelet therapy (SAPT) after drug‐eluting stent implantation reduces major bleeding without increasing the risk of major adverse cardiovascular and cerebral events compared with 12‐month dual antiplatelet therapy (DAPT). The differential effects of P2Y12...

Full description

Saved in:
Bibliographic Details
Main Authors: Juan F. Iglesias, Benjamin Assouline, Quentin Chatelain, Yazan Musayeb, Sophie Degrauwe, Marco Roffi
Format: Article
Language:English
Published: Wiley 2025-03-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.124.036642
Tags: Add Tag
No Tags, Be the first to tag this record!